{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T20:35:53Z","timestamp":1784493353837,"version":"3.55.0"},"reference-count":106,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"unspecified","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["egastro"],"accepted":{"date-parts":[[2023,9,27]]},"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:p>In hepatorenal syndrome-acute kidney injury (HRS-AKI), accurate and early diagnosis is crucial. HRS is a severe condition seen in advanced cirrhosis, requiring prompt recognition and proper management to enhance patient outcomes. Diagnosis of HRS-AKI relies on serum creatinine elevations, similar to other AKI cases in cirrhosis. However, distinguishing HRS-AKI from other renal impairments in these patients can be challenging. Biomarkers and clinical criteria aid in diagnosis and guide treatment. The management of HRS-AKI initially involves improving the haemodynamic profile using albumin and vasoconstrictors like terlipressin, a synthetic vasopressin analogue. Despite some reports linking terlipressin to increased adverse events compared with norepinephrine, it remains the preferred choice in HRS-AKI and acute-on-chronic liver failure due to its faster, stronger response and improved survival. Additional therapies like midodrine (alpha-1 adrenergic agonist), octreotide (somatostatin analogue) and transjugular intrahepatic portosystemic shunt are proposed as adjuvant treatments for HRS-AKI, aiming to improve vasoconstriction and renal blood flow. However, these adjunctive therapies cannot replace the definitive treatment for HRS-AKI\u2014liver transplantation (LT). In cases unresponsive to medical management, LT is the only option to restore liver function and improve renal outcomes. Current evidence favours combined liver and kidney transplantation (CLKT) in certain situations. This review aims to evaluate the present evidence and recommendations on AKI in patients with cirrhosis, the pathophysiology of HRS-AKI, different treatments and indications for LT and CLKT. Understanding the complexities of managing HRS-AKI is crucial for optimising patient care and achieving better outcomes in this challenging clinical setting.<\/jats:p>","DOI":"10.1136\/egastro-2023-100009","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T12:40:35Z","timestamp":1700743235000},"page":"e100009","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Advances in the diagnosis and management of hepatorenal syndrome: insights into HRS-AKI and liver transplantation"],"prefix":"10.1136","volume":"1","author":[{"given":"Jorge","family":"Arnold","sequence":"first","affiliation":[{"name":"Departamento de Gastroenterolog\u00eda, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Avila","sequence":"additional","affiliation":[{"name":"Departamento de Nefrolog\u00eda, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Idalsoaga","sequence":"additional","affiliation":[{"name":"Departamento de Gastroenterolog\u00eda, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Antonio","family":"Diaz","sequence":"additional","affiliation":[{"name":"Departamento de Gastroenterolog\u00eda, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Ayala Valverde","sequence":"additional","affiliation":[{"name":"Departamento de Medicina Interna, Cl\u00ednica D\u00e1vila, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Ayares","sequence":"additional","affiliation":[{"name":"Departamento de Gastroenterolog\u00eda, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Arrese","sequence":"additional","affiliation":[{"name":"Departamento de Gastroenterolog\u00eda, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Roessler","sequence":"additional","affiliation":[{"name":"Departamento de Nefrolog\u00eda, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Huidobro","sequence":"additional","affiliation":[{"name":"Departamento de Nefrolog\u00eda, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hudson","sequence":"additional","affiliation":[{"name":"Department of Medicine, London Health Sciences Centre, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Qasim","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Medicine, London Health Sciences Centre, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8561-396X","authenticated-orcid":false,"given":"Juan Pablo","family":"Arab","sequence":"additional","affiliation":[{"name":"Departamento de Gastroenterolog\u00eda, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"},{"name":"Department of Medicine, London Health Sciences Centre, London, Ontario, Canada"},{"name":"Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"key":"2025081719090462000_1.2.e100009.1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41572-018-0022-7","article-title":"Hepatorenal syndrome","volume":"4","author":"Gin\u00e8s","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2025081719090462000_1.2.e100009.2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22605"},{"key":"2025081719090462000_1.2.e100009.3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25735"},{"key":"2025081719090462000_1.2.e100009.4","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jhep.2019.12.020","article-title":"Development of chronic kidney disease after acute kidney injury in patients with cirrhosis is common and impairs clinical outcomes","volume":"72","author":"Bassegoda","year":"2020","journal-title":"J Hepatol"},{"key":"2025081719090462000_1.2.e100009.5","first-page":"171","article-title":"Acute kidney injury in cirrhosis: implications for liver transplantation","volume":"25","author":"MacDonald","year":"2019","journal-title":"Curr Opin Crit Care"},{"key":"2025081719090462000_1.2.e100009.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.01.035"},{"key":"2025081719090462000_1.2.e100009.7","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90031-7"},{"key":"2025081719090462000_1.2.e100009.8","first-page":"274","article-title":"Hepatorenal syndrome:response to terlipressin and albumin and its determinants","volume":"32","author":"Sarwar","year":"2016","journal-title":"Pak J Med Sci"},{"key":"2025081719090462000_1.2.e100009.9","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0006872020"},{"key":"2025081719090462000_1.2.e100009.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00408.x"},{"key":"2025081719090462000_1.2.e100009.11","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.923805","article-title":"Application of the molecular adsorbent recirculating system in type 1 hepatorenal syndrome in the course of alcohol-related acute on chronic liver failure","volume":"26","author":"Kade","year":"2020","journal-title":"Med Sci Monit"},{"key":"2025081719090462000_1.2.e100009.12","doi-asserted-by":"publisher","DOI":"10.3109\/08860229509026250"},{"key":"2025081719090462000_1.2.e100009.13","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/TP.0000000000000438","article-title":"Outcomes of liver transplantation alone after listing for simultaneous kidney: comparison to simultaneous liver kidney transplantation","volume":"99","author":"Hmoud","year":"2015","journal-title":"Transplantation"},{"key":"2025081719090462000_1.2.e100009.14","doi-asserted-by":"crossref","unstructured":"Nagai S , Safwan M , Collins K , et al . Liver alone or simultaneous liver-kidney transplant? Pretransplant chronic kidney disease and post-transplant outcome - a retrospective study. Transpl Int 2018. doi:10.1111\/tri.13275 [Epub ahead of print 2 May 2018].","DOI":"10.1111\/tri.13275"},{"key":"2025081719090462000_1.2.e100009.15","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1097\/01.tp.0000241104.58576.e6","article-title":"Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: analysis of UNOS database","volume":"82","author":"Simpson","year":"2006","journal-title":"Transplantation"},{"key":"2025081719090462000_1.2.e100009.16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/TP.0b013e3182590d6b","article-title":"Combined liver-kidney transplantation is preferable to liver transplant alone for cirrhotic patients with renal failure","volume":"94","author":"Fong","year":"2012","journal-title":"Transplantation"},{"key":"2025081719090462000_1.2.e100009.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.12.029"},{"key":"2025081719090462000_1.2.e100009.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.09.156"},{"key":"2025081719090462000_1.2.e100009.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.07.002"},{"key":"2025081719090462000_1.2.e100009.20","doi-asserted-by":"crossref","first-page":"101822","DOI":"10.1016\/j.clinre.2021.101822","article-title":"Acute kidney injury in patients with cirrhosis: prospective longitudinal study in 405 patients","volume":"46","author":"Moga","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2025081719090462000_1.2.e100009.21","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m2687","article-title":"Hepatorenal syndrome: pathophysiology, diagnosis, and management","volume":"370","author":"Simonetto","year":"2020","journal-title":"BMJ"},{"key":"2025081719090462000_1.2.e100009.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2215289"},{"key":"2025081719090462000_1.2.e100009.23","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/jgh.13983","article-title":"Serum Cystatin C level: an excellent predictor of mortality in patients with cirrhotic ascites","volume":"33","author":"Seo","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"2025081719090462000_1.2.e100009.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14903-3"},{"key":"2025081719090462000_1.2.e100009.25","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01340406"},{"key":"2025081719090462000_1.2.e100009.26","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jceh.2021.09.019","article-title":"Fractional excretion of sodium and urea in differentiating acute kidney injury phenotypes in decompensated cirrhosis","volume":"12","author":"Gowda","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"2025081719090462000_1.2.e100009.27","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v8.i34.1497"},{"key":"2025081719090462000_1.2.e100009.28","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29772"},{"key":"2025081719090462000_1.2.e100009.29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.semnephrol.2018.10.002","article-title":"Epidemiology, pathophysiology, and management of hepatorenal syndrome","volume":"39","author":"Amin","year":"2019","journal-title":"Semin Nephrol"},{"key":"2025081719090462000_1.2.e100009.30","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jhep.2012.04.028","article-title":"Prospective assessment of renal histopathological lesions in patients with end-stage liver disease: effects on long-term renal function after liver transplantation","volume":"57","author":"Calmus","year":"2012","journal-title":"J Hepatol"},{"key":"2025081719090462000_1.2.e100009.31","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/ndt\/gfz068","article-title":"Acute kidney failure in the cirrhotic patient: management, kidney biopsy and dual kidney liver transplantation indication","volume":"35","author":"Fernandez-Lorente","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"2025081719090462000_1.2.e100009.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(01)99000-6"},{"key":"2025081719090462000_1.2.e100009.33","doi-asserted-by":"crossref","DOI":"10.12659\/AOT.925891","article-title":"Clinical relevance of kidney biopsy in patients qualified for liver transplantation and after this procedure in the model for end-stage liver disease (MELD) era: where are we today","volume":"25","author":"Wieliczko","year":"2020","journal-title":"Ann Transplant"},{"key":"2025081719090462000_1.2.e100009.34","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840080532"},{"key":"2025081719090462000_1.2.e100009.35","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20766"},{"key":"2025081719090462000_1.2.e100009.36","first-page":"112D","article-title":"Update on peripheral arterial vasodilation, ascites and hepatorenal syndrome in cirrhosis","volume":"14 Suppl D","author":"Knotek","year":"2000","journal-title":"Can J Gastroenterol"},{"key":"2025081719090462000_1.2.e100009.37","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21920"},{"key":"2025081719090462000_1.2.e100009.38","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14037"},{"key":"2025081719090462000_1.2.e100009.39","doi-asserted-by":"publisher","DOI":"10.1159\/000448437"},{"key":"2025081719090462000_1.2.e100009.40","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/liv.12047","article-title":"Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis","volume":"33","author":"Shah","year":"2013","journal-title":"Liver Int"},{"key":"2025081719090462000_1.2.e100009.41","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.30875","article-title":"Redefining cirrhotic cardiomyopathy for the modern era","volume":"71","author":"Izzy","year":"2020","journal-title":"Hepatology"},{"key":"2025081719090462000_1.2.e100009.42","doi-asserted-by":"crossref","DOI":"10.1007\/s11894-020-00783-1","article-title":"Cirrhotic cardiomyopathy","volume":"22","author":"Yoon","year":"2020","journal-title":"Curr Gastroenterol Rep"},{"key":"2025081719090462000_1.2.e100009.43","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cld.2021.01.012","article-title":"Current concepts of cirrhotic cardiomyopathy","volume":"25","author":"Izzy","year":"2021","journal-title":"Clin Liver Dis"},{"key":"2025081719090462000_1.2.e100009.44","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-005-0005-5"},{"key":"2025081719090462000_1.2.e100009.45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804635"},{"key":"2025081719090462000_1.2.e100009.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2018.05.011"},{"key":"2025081719090462000_1.2.e100009.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.09.035"},{"key":"2025081719090462000_1.2.e100009.48","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.kint.2017.04.048","article-title":"Acute kidney injury in acute-on-chronic liver failure: where does hepatorenal syndrome fit?","volume":"92","author":"Davenport","year":"2017","journal-title":"Kidney Int"},{"key":"2025081719090462000_1.2.e100009.49","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.107789"},{"key":"2025081719090462000_1.2.e100009.50","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-308874"},{"key":"2025081719090462000_1.2.e100009.51","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cgh.2017.05.041","article-title":"New developments in hepatorenal syndrome","volume":"16","author":"Mindikoglu","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025081719090462000_1.2.e100009.52","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14366"},{"key":"2025081719090462000_1.2.e100009.53","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.03.005"},{"key":"2025081719090462000_1.2.e100009.54","doi-asserted-by":"crossref","unstructured":"Arun J S , Thomas D B , Norah A T , et al . Renal failure in cirrhosis. In: Zakim and Boyer\u2019s hepatology. Elsevier, 2018: 262\u201380.","DOI":"10.1016\/B978-0-323-37591-7.00017-3"},{"key":"2025081719090462000_1.2.e100009.55","doi-asserted-by":"crossref","unstructured":"Claudio R , John A K , Rinaldo B , et al . Vasoactive drugs and renal function. In: Critical care nephrology. W.B. Saunders, 2009: 1723\u20136.","DOI":"10.1016\/B978-1-4160-4252-5.50326-9"},{"key":"2025081719090462000_1.2.e100009.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.05.022"},{"key":"2025081719090462000_1.2.e100009.57","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309262"},{"key":"2025081719090462000_1.2.e100009.58","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/jgh.12195","article-title":"Hemodynamic effects of continuous versus bolus infusion of terlipressin for portal hypertension: a randomized comparison","volume":"28","author":"Ding","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"2025081719090462000_1.2.e100009.59","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12072-022-10416-6","article-title":"Low-dose continuous terlipressin infusion is effective and safer than intravenous bolus injections in reducing portal pressure and control of acute variceal bleeding","volume":"17","author":"Arora","year":"2023","journal-title":"Hepatol Int"},{"key":"2025081719090462000_1.2.e100009.60","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28396"},{"key":"2025081719090462000_1.2.e100009.61","doi-asserted-by":"crossref","DOI":"10.2174\/138945009788488396","article-title":"Terlipressin continuous infusion: please mind the solvent","volume":"10","author":"Rodriguez-Nunez","year":"2009","journal-title":"Curr Drug Targets"},{"key":"2025081719090462000_1.2.e100009.62","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2011.07.017"},{"key":"2025081719090462000_1.2.e100009.63","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010431","article-title":"Terlipressin in the treatment of hepatorenal syndrome: a systematic review and meta-analysis","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"2025081719090462000_1.2.e100009.64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107466","article-title":"Terlipressin versus norepinephrine in the treatment of hepatorenal syndrome: a systematic review and meta-analysis","volume":"9","author":"Nassar Junior","year":"2014","journal-title":"PLoS One"},{"key":"2025081719090462000_1.2.e100009.65","doi-asserted-by":"crossref","unstructured":"Krag A , M\u00f8ller S . Safety of terlipressin for hepatorenal syndrome. Front Gastrointest Res 2010:178\u201388. doi:10.1159\/isbn.978-3-8055-9592-6","DOI":"10.1159\/000318999"},{"key":"2025081719090462000_1.2.e100009.66","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2008290"},{"key":"2025081719090462000_1.2.e100009.67","doi-asserted-by":"crossref","first-page":"520","DOI":"10.14309\/ajg.0000000000001628","article-title":"Board review vignette: lessons learned in the management of hepatorenal syndrome type 1 with terlipressin","volume":"117","author":"Gonzalez","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"2025081719090462000_1.2.e100009.68","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/lt.26072","article-title":"The current management of hepatorenal syndrome-acute kidney injury in the United States and the potential of Terlipressin","volume":"27","author":"Flamm","year":"2021","journal-title":"Liver Transpl"},{"key":"2025081719090462000_1.2.e100009.69","first-page":"1564","article-title":"Early versus standard initiation of Terlipressin for HRS-AKI in ACLF - a randomized controlled trial (ETERLI study)","volume":"76 Suppl 1","author":"Hitesh","year":"2022","journal-title":"Abstracts Hepatology"},{"key":"2025081719090462000_1.2.e100009.70","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-010-2057-4"},{"key":"2025081719090462000_1.2.e100009.71","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.2.534"},{"key":"2025081719090462000_1.2.e100009.72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.024"},{"key":"2025081719090462000_1.2.e100009.73","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/apt.13912","article-title":"Systematic review with meta-analysis: vasoactive drugs for the treatment of hepatorenal syndrome type 1","volume":"45","author":"Gifford","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2025081719090462000_1.2.e100009.74","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30208"},{"key":"2025081719090462000_1.2.e100009.75","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.40899.x"},{"key":"2025081719090462000_1.2.e100009.76","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290629"},{"key":"2025081719090462000_1.2.e100009.77","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-006-9312-0"},{"key":"2025081719090462000_1.2.e100009.78","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27709"},{"key":"2025081719090462000_1.2.e100009.79","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280219"},{"key":"2025081719090462000_1.2.e100009.80","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2018.01.123"},{"key":"2025081719090462000_1.2.e100009.81","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20262"},{"key":"2025081719090462000_1.2.e100009.82","doi-asserted-by":"crossref","first-page":"G275","DOI":"10.1152\/ajpgi.00094.2017","article-title":"Transjugular intrahepatic portosystemic shunt: impact on systemic hemodynamics and renal and cardiac function in patients with cirrhosis","volume":"314","author":"Busk","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2025081719090462000_1.2.e100009.83","first-page":"1753","article-title":"Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation","volume":"50","author":"Testino","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"2025081719090462000_1.2.e100009.84","doi-asserted-by":"publisher","DOI":"10.1136\/gut.47.2.288"},{"key":"2025081719090462000_1.2.e100009.85","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1007\/s10620-020-06136-2","article-title":"Inpatient mortality benefit with transjugular intrahepatic portosystemic shunt for hospitalized hepatorenal syndrome patients","volume":"65","author":"Charilaou","year":"2020","journal-title":"Dig Dis Sci"},{"key":"2025081719090462000_1.2.e100009.86","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-023-07261-9","article-title":"Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial","volume":"24","author":"Ripoll","year":"2023","journal-title":"Trials"},{"key":"2025081719090462000_1.2.e100009.87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2015.05.006"},{"key":"2025081719090462000_1.2.e100009.88","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13508","article-title":"Procedure-related bleeding risk in patients with cirrhosis and severe thrombocytopenia","volume":"51","author":"Alvaro","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"2025081719090462000_1.2.e100009.89","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s12664-015-0584-1","article-title":"Coagulopathy in cirrhosis: a prospective study to correlate conventional tests of coagulation and bleeding following invasive procedures in Cirrhotics","volume":"34","author":"Shah","year":"2015","journal-title":"Indian J Gastroenterol"},{"key":"2025081719090462000_1.2.e100009.90","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.4254\/wjh.v8.i25.1075","article-title":"Therapeutic alternatives for the treatment of type 1 hepatorenal syndrome: a Delphi technique-based consensus","volume":"8","author":"Arab","year":"2016","journal-title":"World J Hepatol"},{"key":"2025081719090462000_1.2.e100009.91","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jceh.2020.09.005","article-title":"INASL-ISN joint position statements on management of patients with simultaneous liver and kidney disease","volume":"11","author":"Arora","year":"2021","journal-title":"J Clin Exp Hepatol"},{"key":"2025081719090462000_1.2.e100009.92","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.xkme.2020.09.015","article-title":"Acute kidney injury treatment in decompensated cirrhosis: a focus on kidney replacement therapy","volume":"3","author":"Allegretti","year":"2021","journal-title":"Kidney Med"},{"key":"2025081719090462000_1.2.e100009.93","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1525-139X.2008.00539.x","article-title":"Continuous renal replacement therapies in patients with liver disease","volume":"22","author":"Davenport","year":"2009","journal-title":"Semin Dial"},{"key":"2025081719090462000_1.2.e100009.94","doi-asserted-by":"crossref","first-page":"687","DOI":"10.23876\/j.krcp.21.033","article-title":"Clinical outcomes and prognostic factors of mortality in liver cirrhosis patients on continuous renal replacement therapy in two tertiary hospitals in Korea","volume":"40","author":"Jeon","year":"2021","journal-title":"Kidney Res Clin Pract"},{"key":"2025081719090462000_1.2.e100009.95","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2215\/CJN.03610417","article-title":"Prognosis of patients with cirrhosis and AKI who initiate RRT","volume":"13","author":"Allegretti","year":"2018","journal-title":"CJASN"},{"key":"2025081719090462000_1.2.e100009.96","first-page":"39","article-title":"Comparative evaluation of continuous veno-venous hemodiafiltration and continuous arterio-venous hemodiafiltration in patients of hepatic failure and \/ or hepatorenal syndrome","volume":"67","author":"Nand","year":"2019","journal-title":"J Assoc Physicians India"},{"key":"2025081719090462000_1.2.e100009.97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232516","article-title":"Regional citrate anticoagulation versus no-anticoagulation for continuous venovenous hemofiltration in patients with liver failure and increased bleeding risk: a retrospective case-control study","volume":"15","author":"Yu","year":"2020","journal-title":"PLOS ONE"},{"key":"2025081719090462000_1.2.e100009.98","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-020-2801-2","article-title":"In severe liver disease, citrate can be used safely: the question remains\u2014by which mechanism","volume":"24","author":"Honore","year":"2020","journal-title":"Crit Care"},{"key":"2025081719090462000_1.2.e100009.99","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/cld.980","article-title":"PRO: simultaneous liver-kidney transplantation in the current era: still the best option","volume":"16","author":"Enestvedt","year":"2020","journal-title":"Clinical Liver Disease"},{"key":"2025081719090462000_1.2.e100009.100","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01526.x"},{"key":"2025081719090462000_1.2.e100009.101","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2002.32504"},{"key":"2025081719090462000_1.2.e100009.102","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5362810","article-title":"Clinical outcomes after liver transplantation for hepatorenal syndrome: a systematic review and meta-analysis","volume":"2018","author":"Utako","year":"2018","journal-title":"Biomed Res Int"},{"key":"2025081719090462000_1.2.e100009.103","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09600912"},{"key":"2025081719090462000_1.2.e100009.104","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/SLA.0000000000001801","article-title":"Avoiding futility in simultaneous liver-kidney transplantation","volume":"265","author":"Lunsford","year":"2017","journal-title":"Ann Surg"},{"key":"2025081719090462000_1.2.e100009.105","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/lt.21877","article-title":"Report of the first International liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation","volume":"15","author":"Charlton","year":"2009","journal-title":"Liver Transpl"},{"key":"2025081719090462000_1.2.e100009.106","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2012.04182.x"}],"container-title":["eGastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/egastro-2023-100009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T02:10:23Z","timestamp":1755483023000},"score":1,"resource":{"primary":{"URL":"http:\/\/egastroenterology.bmj.com\/lookup\/doi\/10.1136\/egastro-2023-100009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":106,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,11,23]]},"published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.1136\/egastro-2023-100009"],"URL":"https:\/\/doi.org\/10.1136\/egastro-2023-100009","relation":{},"ISSN":["2766-0125","2976-7296"],"issn-type":[{"value":"2766-0125","type":"print"},{"value":"2976-7296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}